• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIABETES CARE INC LINGO GLUCOSE SYSTEM; N/A

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIABETES CARE INC LINGO GLUCOSE SYSTEM; N/A Back to Search Results
Model Number 77263-01
Medical Device Problem Code High Readings (2459)
Health Effect - Clinical Codes Hypoglycemia (1912); Dizziness (2194); Anxiety (2328); Loss of consciousness (2418); Cognitive Changes (2551)
Date of Event 11/09/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The reported product is not expected to be returned as reporter indicated the device was discarded.An investigation has been performed for the reported complaint and there was no indication that the product did not meet specification.The device history records (dhrs) for the product were reviewed and the dhrs showed the product passed all tests prior to release.The most probable root causes associated with this failure mode are disconnected, faulty or damaged components, software/data corruption, or misuse.However, mitigation's are in place to reduce and prevent such issues.All vital manufacturing steps are validated, monitored, and verified during manufacturing to ensure the system is in conformance with the verified design.All vital functions are monitored by the system and, when necessary, function is suspended to safeguard against inaccurate results.Labeling is provided to instruct the user on the intended use of all vital parts of the system to minimize misuse.All complaints and complaint trends are investigated to determine if there is a product defect/ deficiency.If a product defect/ deficiency is identified, a risk evaluation is completed and compared to the risk management report, to ensure the risk profile has not changed.Additionally, as a part of abbott¿s post-market surveillance process, all risk evaluations with associated complaint data are reviewed annually to determine if the risk profiles have changed as compared to the product risk management reports.These monitoring processes ensure that all product risk profiles remain acceptable and have a positive benefit/ risk ratio.No further investigation is planned.In the event that product is received, a physical investigation will be performed per adc's established processes and procedures and a report will be submitted upon completion of investigation.The date of event is unknown.The date entered in section b3 is the date abbott diabetes care became aware of the event.All pertinent information available to abbott diabetes care has been submitted.
 
Event or Problem Description
A high readings issue with the abbott diabetes care (adc) lingo glucose system was reported.The customer received unspecified higher sensor scan results compared to how the customer was feeling.It is unknown whether the customer noted a trend arrow on the device.The customer experienced, anxiety, dizziness, mood swings, and loss of consciousness.The customer was unable to self-treat and required treatment of orange juice and glucose tablets administered by a healthcare professional (hcp) for a diagnosis of hypoglycemia.There was no report of death or permanent impairment associated with this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LINGO GLUCOSE SYSTEM
Common Device Name
N/A
Manufacturer (Section D)
ABBOTT DIABETES CARE INC
1360 south loop road
alameda CA 94502 7001
Manufacturer Contact
patricia reis castro
1360 south loop road
alameda, CA 94502-7001
4157205405
MDR Report Key23729573
Report Number2954323-2025-47361
Device Sequence Number10631909
Product Code SAF
UDI-Device Identifier00357599848002
UDI-Public(01)00357599848002(17)2025-12-31(10)KTP012314(91)77263-01
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
K233655
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 12/05/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Expiration Date12/31/2025
Device Model Number77263-01
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/09/2025
Initial Report FDA Received Date12/05/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/05/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-